CRON
Price
$3.23
Change
+$0.09 (+2.87%)
Updated
Sep 14 closing price
Capitalization
1.2B
57 days until earnings call
Intraday BUY SELL Signals
SIGA
Price
$3.15
Change
+$0.12 (+3.96%)
Updated
Sep 14 closing price
Capitalization
225.97M
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRON vs SIGA

CRON vs SIGA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRON vs. SIGA commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Hold and SIGA is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($1.2B) has a higher market cap than SIGA($226M). CRON has higher P/E ratio than SIGA: CRON (17.03) vs SIGA (11.14). CRON YTD gains are higher at: 23.004 vs. SIGA (-41.721). CRON has higher annual earnings (EBITDA): 9.02M vs. SIGA (-10.55M). CRON has more cash in the bank: 797M vs. SIGA (118M). SIGA has less debt than CRON: SIGA (439K) vs CRON (1.3M). CRON has higher revenues than SIGA: CRON (179M) vs SIGA (53.7M).
CRONSIGACRON / SIGA
Capitalization1.2B226M531%
EBITDA9.02M-10.55M-85%
Gain YTD23.004-41.721-55%
P/E Ratio17.0311.14153%
Revenue179M53.7M333%
Total Cash797M118M675%
Total Debt1.3M439K295%
FUNDAMENTALS RATINGS
CRON vs SIGA: Fundamental Ratings
CRON
SIGA
OUTLOOK RATING
1..100
8233
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
1
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8091
PRICE GROWTH RATING
1..100
4365
P/E GROWTH RATING
1..100
979
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGA's Valuation (1) in the Pharmaceuticals Other industry is somewhat better than the same rating for CRON (46). This means that SIGA’s stock grew somewhat faster than CRON’s over the last 12 months.

SIGA's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CRON (100). This means that SIGA’s stock grew similarly to CRON’s over the last 12 months.

CRON's SMR Rating (80) in the Pharmaceuticals Other industry is in the same range as SIGA (91). This means that CRON’s stock grew similarly to SIGA’s over the last 12 months.

CRON's Price Growth Rating (43) in the Pharmaceuticals Other industry is in the same range as SIGA (65). This means that CRON’s stock grew similarly to SIGA’s over the last 12 months.

SIGA's P/E Growth Rating (9) in the Pharmaceuticals Other industry is significantly better than the same rating for CRON (97). This means that SIGA’s stock grew significantly faster than CRON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRONSIGA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 20 days ago
73%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
77%
Bearish Trend 5 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
77%
COMPARISON
Comparison
Sep 15, 2026
Stock price -- (CRON: $3.23 vs. SIGA: $3.15)
Brand notoriety: CRON and SIGA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRON: 73% vs. SIGA: 72%
Market capitalization -- CRON: $1.2B vs. SIGA: $225.97M
CRON [@Pharmaceuticals: Generic] is valued at $1.2B. SIGA’s [@Pharmaceuticals: Generic] market capitalization is $225.97M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $63.66B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 0 FA rating(s) are green while SIGA’s FA Score has 2 green FA rating(s).

  • CRON’s FA Score: 0 green, 5 red.
  • SIGA’s FA Score: 2 green, 3 red.
According to our system of comparison, SIGA is a better buy in the long-term than CRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 3 TA indicator(s) are bullish while SIGA’s TA Score has 6 bullish TA indicator(s).

  • CRON’s TA Score: 3 bullish, 5 bearish.
  • SIGA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SIGA is a better buy in the short-term than CRON.

Price Growth

CRON (@Pharmaceuticals: Generic) experienced а -0.77% price change this week, while SIGA (@Pharmaceuticals: Generic) price change was -4.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.68%. For the same industry, the average monthly price growth was -3.54%, and the average quarterly price growth was +33.30%.

Reported Earning Dates

CRON is expected to report earnings on Nov 11, 2026.

SIGA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.68% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
CRON
Daily Signal:
Gain/Loss:
SIGA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QFVOX34.74N/A
N/A
Pear Tree Polaris Foreign Value Ord
GLVNX79.91N/A
N/A
Invesco Global Focus R
FWMIX67.41-0.18
-0.27%
American Fds Washington Mutual F-3
VSFAX29.52-0.09
-0.30%
Federated Hermes MDT Small Cap Value A
JCNAX30.47-0.73
-2.34%
Janus Henderson Contrarian A

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+3.03%
SNDL - CRON
73%
Closely correlated
+2.24%
ACB - CRON
67%
Closely correlated
+1.87%
CGC - CRON
64%
Loosely correlated
+1.15%
TLRY - CRON
64%
Loosely correlated
+2.99%
TRLV - CRON
55%
Loosely correlated
+2.74%
More

SIGA and

Correlation & Price change

A.I.dvisor tells us that SIGA and EBS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGA and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGA
1D Price
Change %
SIGA100%
+3.96%
EBS - SIGA
31%
Poorly correlated
+2.41%
ETON - SIGA
27%
Poorly correlated
+0.95%
HROW - SIGA
27%
Poorly correlated
-1.19%
AMRX - SIGA
26%
Poorly correlated
+1.23%
SBFM - SIGA
25%
Poorly correlated
+0.94%
More